Eli Lilly
Apr 25, 2012 at 12:52 | Source: Moneycontrol.com
Mar 13, 2012 at 10:30 | Source: Moneycontrol.com
Feb 03, 2012 at 16:56 | Source: Reuters
Feb 03, 2012 at 15:05 | Source: Moneycontrol.com
Jan 31, 2012 at 13:45 | Source: CNBC-TV18
Oct 03, 2011 at 19:16 | Source: PTI
Videos »
Photos »
/ 
Interact & exchange stock tips & market info »
Related News »
Eli Lilly (LLY) and partner Boehringer Ingelheim Pharmaceuticals announced on Thursday positive results for a late-stage study of an experimental treatment for type 2 diabetes in black and African American adult patients. The once-daily tablet ...
May 23, 2012 at 23:58 | Source: FOXBusiness
Eli Lilly & Co. (LLY) said dulaglutide, an investigational treatment for Type 2 diabetes, met a primary endpoint for blood pressure and heart rate effects in a 16-week study. Dulaglutide, which is being studied as a once-weekly treatment for ...
May 22, 2012 at 12:54 | Source: NASDAQ
The roughly 60,000-member, $1 billion Eli Lilly Federal Credit Union in Indianapolis has repurchased a card portfolio that it had originally sold in 2002. “We sold it at the time because we didn't believe we had the expertise we needed for ...
May 23, 2012 at 15:30 | Source: Credit Union Times
INDIANAPOLIS, May 14, 2012 /PRNewswire/ -- Eli Lilly and Company (LLY) will present data from several molecules that make up its clinical oncology pipeline during the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO ...
May 26, 2012 at 07:41 | Source: Yahoo Finance
Eli Lilly and Company (LLY) recently presented positive phase II data on its type II diabetes candidate, dulaglutide. The company said that dulaglutide met its primary endpoint in the study. Dulaglutide is a glucagon-like peptide 1 (GLP-1 ...
May 23, 2012 at 22:32 | Source: Yahoo Finance
Eli Lilly and Company - Product Pipeline Review - 2012 - Our pharmaceuticals report, Eli Lilly and Company - Product Pipeline Review - 2012 provides data on the Eli Lilly and Company's research and development focus. The report includes information on ...
May 17, 2012 at 12:24 | Source: Transworld News
Eli Lilly & Co. (LLY) and AstraZeneca Plc (AZN) won’t have an easier time gaining more of the market for blood thinners dominated by Bristol-Myers Squibb Co. (BMY)’s Plavix after the drug lost U.S. patent protection yesterday. Lilly’s ...
May 18, 2012 at 11:04 | Source: Bloomberg
Today, Eli Lilly ($LLY) demonstrated that its late-stage diabetes drug dulaglutide cleared an important cardiovascular safety hurdle, impressing analysts with a savvy clinical game plan on an important experimental product in its pipeline.
May 22, 2012 at 15:24 | Source: FierceBiotech
Eli Lilly & Co. and Abbott Laboratories are offering help to the 13.8 million American men with low levels of testosterone. Doctors warn demand for the treatments could lead to overuse with deadly side effects. In what may become one of the most sought ...
May 27, 2012 at 02:54 | Source: Monterey County Herald